Stocks and Investing Stocks and Investing
Wed, December 6, 2017
Tue, December 5, 2017

John Newman Initiated (BLUE) at Strong Buy and Held Target at $202 on, Dec 5th, 2017


Published on 2024-10-26 01:21:35 - WOPRAI, John Newman
  Print publication without navigation


John Newman of Canaccord Genuity, Initiated "bluebird bio, Inc." (BLUE) at Strong Buy and Held Target at $202 on, Dec 5th, 2017.

John has made no other calls on BLUE in the last 4 months.



There are 7 other peers that have a rating on BLUE. Out of the 7 peers that are also analyzing BLUE, 3 agree with John's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Josh Schimmer of "Evercore ISI Group" Downgraded from Buy to Hold on, Monday, November 6th, 2017
  • Matthew Harrison of "Morgan Stanley" Upgraded from Sell to Hold on, Friday, November 3rd, 2017
  • Biren Amin of "Jefferies" Downgraded from Strong Buy to Hold on, Wednesday, October 11th, 2017


These are the ratings of the 4 analyists that currently disagree with John


  • Jason McCarthy of "Maxim Group" Maintained at Strong Buy with Increased Target to $200 on, Thursday, November 30th, 2017
  • Dane Leone of "BTIG" Upgraded from Hold to Strong Buy on, Thursday, November 2nd, 2017
  • Gena Wang of "Barclays" Maintained at Buy with Increased Target to $162 on, Thursday, November 2nd, 2017
  • Matthew Luchini of "BMO Capital" Maintained at Buy with Increased Target to $162 on, Monday, October 30th, 2017

Contributing Sources